Pharmaceuticals Excipients Market
Market Insights on Pharmaceuticals Excipients covering sales outlook, demand forecast & up-to-date key trends
Pharmaceuticals Excipients Market by Functionality & Region - Forecast 2022 – 2032
Pharmaceuticals Excipients Market Outlook (2022-2032)
[250 Pages Report] The pharmaceuticals excipients market is expected to register a CAGR of 6% during the forecast period, up from US$ 7.9 Bn in 2021 to reach a valuation of US$ 10.9 Bn by 2026.
- Increasing adoption of binders in pharmaceutical products, advancements in functional excipients, and the emergence of innovative technologies are primarily driving the market growth of global pharmaceuticals excipients. These factors have been attributed to the emergence of new technologies and pharmaceutical ingredients.
- Pharmaceuticals excipients market growth may be hindered by the absence of a structured approval process, fluctuations in the availability of raw materials, adverse reactions of excipients, and contamination in formulations of pharmaceuticals.
- Government investments are increasing in healthcare centers to improve diagnosis and treatment procedures, providing opportunities for the pharmaceuticals excipients market.
|
Report Attribute |
|
|
bEstimated Base Year Value (2021) |
US$ 7.9 Bn |
|
Expected Market Value (2026) |
US$ 10.9 Bn |
|
Projected Growth Rate (2022-2032) |
6% |
Let us know your requirement to get
100% FREE customization
North America to Dominate the Market
Over the forecast period, the pharmaceuticals excipients market is expected to exhibit a similar trend to that of North America, where it holds the majority share. The growth of the market will be primarily driven by factors such as the fast-growing pharmaceutical industry, the increasing demand for functional excipients, the presence of major players in the region, and technological advances.
Furthermore, the introduction of technologically advanced or superior excipients is also one of the factors driving the growth of this market. Accordingly, Lubrizol Life Science (LLS) Health, one of the world's leading companies in accelerating success and innovation in pharmaceutical development, launched Apisolex for the first time in May 2022.
This excipient is a novel solubility-enhancing excipient that can be used in parenteral drug products. By utilizing this technology, we can overcome solubility hurdles that cannot be overcome by existing excipients or manufacturing processes.
What are the Key Dynamics to the Pharmaceuticals Excipients Market Share?
The global sales of pharmaceutical excipients are driven by factors such as growing demand for functional excipients, increasing demand for generics, and the emergence of new excipients in the market.
Thousands of different excipients are used in medicines and makeup, on average, about 90% of each product. As a result, they represent a market value accounting for about 0.5% of the total demand for pharmaceutical excipients.
The sales of pharmaceutical excipients are expected to grow at a healthy CAGR during the forecast period due to increasing utilization of parenteral products due to the rise in the global burden of chronic and lifestyle diseases and heavy investments by the pharmaceuticals industry in the development of biologics.
Additionally, the adoption of modern science like nanotechnology to impart innovative functions to the excipients used for target-specific functionality of the active ingredients, resulting in reduced drug toxicity, a major challenge faced by the pharmaceutical industry, is also propelling the demand for pharmaceutical excipients during the forecast period.
The product demand is increasing in emerging markets like Asia-Pacific and Latin America; therefore, proper expansion planning focuses on various R&D and innovations to launch new products would be a great opportunity.
The sales of pharmaceutical excipients are hampered to a certain extent by the factors like declining investments in R&D by excipients producers and increasing regulatory requirements leading to scarcity of U.S. FDA-approved manufacturing sites.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystEurope Shows Significant Growth
Due to technological advancements, the growing investments into the development of biologics and superior dosage forms, and the presence of key players in the region, Europe is expected to show significant growth in the global pharmaceuticals excipients market in the forecasted period.
The large share of this region can be attributed to the presence of many pharmaceutical giants with large production capacities leading to the high consumption of excipients in this region. Due to the increasing emphasis on superior pharmaceutical products, generics, and biosimilars, the demand for novel excipients has also risen, and this trend is expected to drive the growth of the market.
It has been estimated that in 2020, the production of pharmaceuticals in the European region was valued at EUR 286,697 million. In 2021, it will be valued at EUR 300,000 million, according to the report from the European Federation of Pharmaceutical Industries and Associations 2022.
An increase in the value of production is often accompanied by an increase in the number of pharmaceuticals produced, which, in turn, boosts the demand for pharmaceuticals excipients. Furthermore, it is predicted that the market may continue to grow as a result of the expansion of facilities by the market players to develop high-performance ingredients.
Croda International Plc opened a new high-purity excipient manufacturing facility in Mill Hall, London in July 2021. The investment led Croda to develop innovative pharmaceutical excipients for use in smart science as a result of the investment.
Recent Developments
- A long-standing challenge in drug development has been poor bioavailability, a problem CD Formulation intends to solve in March 2022 through tailored solutions for increased bioavailability excipients.
- A pharmaceutical excipient solution provider, DFE Pharma, introduced BioHale, a new product line in April 2021 to help biopharmaceutical companies overcome global supply challenges. In addition to high-quality excipient technology and services, the new line will provide pharmaceutical companies and drug developers with low-endotoxin excipients that promote therapeutic formulation.
- In February 2022, Kerry Group Plc., the world's leading taste and nutrition company, revealed the acquisition of two significant biotechnology companies. These acquisitions strengthened Kerry Group Plc's technology portfolio, manufacturing capabilities, and expertise. Enmex, a Mexican enzyme manufacturer, and c-LEcta, a leading biotechnology innovation company, have been acquired by the company.
Sales of pharmaceuticals excipients are expected to rise due to the significant research and development taking place in the industry. In addition to this, demand for pharmaceutical excipients is rising on account of the fast-increasing biopharmaceuticals sector and the rising acceptance of orphan medications.
Increasing demand for functionality excipients is also projected to contribute to the growth of the pharmaceuticals excipients market share.
The report sheds light on the factors improving the sales of pharmaceuticals excipients and, in turn, the opportunities for the market players. However, the pharmaceuticals excipients market also faces some challenges, which might limit the pharmaceuticals excipients market share from reaching its potential.
Some of the key pharmaceuticals excipients market trends promoting the demand for pharmaceuticals excipients include a strong pharmaceutical manufacturing presence in various emerging countries, which is projected to give profitable growth prospects for the pharmaceutical excipients market share throughout time.
As a result, they offer great efficiency and fewer adverse effects. As a result, they are one of the pharmaceutical excipients market's fastest-growing segments. In addition, cell therapy (for cancer treatment) and gene therapy (for regenerative medicine) are two new concepts that are constantly being developed. This creates a compelling chance for the pharmaceutical excipients market to expand further.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Which is the Key Pharmaceuticals Excipients Market?
The global pharmaceutical excipients market is sub-segmented into 7 key regions- North America, Latin America, East Europe, West Europe, Asia Pacific, and Middle East & Africa.
Developed regions like North America and Europe are expected to experience slow growth in sales of pharmaceutical excipients, due to already established excipients market, during the forecast period while the emerging market like Asia-Pacific is expected to record strong growth during the same period owing to the availability of cheap labor, skills in abundance, strong demand for pharmaceutical excipients and comparatively lower cost of raw materials.
Countries like Brazil, India, and China are expected to be the major contributors in the sales of pharmaceutical excipients in the emerging markets mainly due to the rising per capita income and increase in the number of companies from the developed regions willing to outsource their excipients manufacturing activities due to low manufacturing and labor costs in these regions. In addition, the rising disposable income in this region is also driving the demand for pharmaceutical excipients.
How Strong is the Competition in the Pharmaceuticals Excipients Market?
Major players in the pharmaceutical excipients market are BASF (Germany) and Ashland, Inc. (U.S.), which dominate the sales of pharmaceutical excipients with their diversified product portfolio and aggressive sales strategies.
Some other key players include Avantor Performance Materials, Inc. (U.S.), The Dow Chemical Company (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), Lubrizol Corporation (U.S.), Roquette (France), and Colorcon, Inc. (U.S.)
Business expansions, new product launches, mergers & acquisitions, and collaborations with educational universities are the key strategies most companies adapt to cater to the growing demand for pharmaceutical excipients.
The need for innovative functional excipients in the pharmaceutical industry will lead to innovations in the market, further leading to better sales of pharmaceutical excipients during the forecast period.
Owing to this strategy, leading players continuously introduce several advanced excipients and modified categories of existing excipients in the market.
Scope Of Report
|
Report Attribute |
Details |
|
Growth rate |
CAGR of 6% from 2022 to 2032 |
|
Base year for estimation |
2021 |
|
Historical data |
2015 - 2020 |
|
Forecast period |
2022 - 2032 |
|
Quantitative units |
Revenue in USD million and CAGR from 2022 to 2032 |
|
Report coverage |
Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
|
Segments covered |
Functionality, region |
|
Regional scope |
North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
|
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
|
Key companies profiled |
Ashland Global Holdings, Croda International, BASF SE, Lubrizol Corporation, Evonik Industries AG, Associated British Foods, Roquette Feres, Archer Daniels Midland Company, and DuPont. |
|
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. |
Key Segments
By Functionality:
- Diluents
- Binders
- Disintegrants
- Glidants
- Lubricants
- Tablet Coating
- Films and Coloring Agents
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
The market is likely to register a CAGR of 6% through 2032.
The market is currently valued at US$ 7.9 Bn in 2021.
The market is likely to grow to a valuation of US$ 10.9 Bn by 2026.
North America is likely to be a leading market during the forecast period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Chemical Nature
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Chemical Nature, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Chemical Nature, 2022-2032
5.3.1. Natural Polysaccharides Polymers
5.3.2. Semi-synthetic Polymers
5.3.3. Synthetic Polymers
5.3.4. Inorganic Excipients
5.3.5. Sugar Compounds
5.4. Y-o-Y Growth Trend Analysis By Chemical Nature, 2017-2021
5.5. Absolute $ Opportunity Analysis By Chemical Nature, 2022-2032 Deep-dive segmentation will be available in the sample on request
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Dosage Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Dosage Type, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Dosage Type, 2022-2032
6.3.1. Oral Formulations
6.3.2. Parenteral Formulations
6.3.3. Topical Formulations
6.3.4. Ophthalmic Formulations
6.3.5. Nasal Formulations
6.3.6. Vaginal Formulations
6.3.7. Suppository Formulations
6.4. Y-o-Y Growth Trend Analysis By Dosage Type, 2017-2021
6.5. Absolute $ Opportunity Analysis By Dosage Type, 2022-2032 Deep-dive segmentation will be available in the sample on request
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Functionality
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Functionality, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Functionality, 2022-2032
7.3.1. Diluents
7.3.2. Fillers
7.3.3. Binders
7.3.4. Disintegrants
7.3.5. Lubricants
7.3.6. Glidants
7.3.7. Coating Agents
7.3.8. Colouring Agents
7.3.9. Emulsifying Agents
7.3.10. Preservatives
7.3.11. Vehicles
7.3.12. Others
7.4. Y-o-Y Growth Trend Analysis By Functionality, 2017-2021
7.5. Absolute $ Opportunity Analysis By Functionality, 2022-2032 Deep-dive segmentation will be available in the sample on request
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
8.3.1. Biotechnology and Pharmaceutical Companies
8.3.2. Contract Development and Manufacturing Organizations (CDMOs)
8.3.3. Research Laboratories
8.3.4. Others
8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
8.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request
9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia & Pacific
9.3.6. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Chemical Nature
10.2.3. By Dosage Type
10.2.4. By Functionality
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Chemical Nature
10.3.3. By Dosage Type
10.3.4. By Functionality
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Mexico
11.2.1.2. Brazil
11.2.1.3. Rest of Latin America
11.2.2. By Chemical Nature
11.2.3. By Dosage Type
11.2.4. By Functionality
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Chemical Nature
11.3.3. By Dosage Type
11.3.4. By Functionality
11.3.5. By End User
11.4. Key Takeaways
12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. U.K.
12.2.1.5. Spain
12.2.1.6. BENELUX
12.2.1.7. Russia
12.2.1.8. Rest of Europe
12.2.2. By Chemical Nature
12.2.3. By Dosage Type
12.2.4. By Functionality
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Chemical Nature
12.3.3. By Dosage Type
12.3.4. By Functionality
12.3.5. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Chemical Nature
13.2.3. By Dosage Type
13.2.4. By Functionality
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Chemical Nature
13.3.3. By Dosage Type
13.3.4. By Functionality
13.3.5. By End User
13.4. Key Takeaways
14. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. India
14.2.1.2. ASEAN
14.2.1.3. Australia and New Zealand
14.2.1.4. Rest of South Asia & Pacific
14.2.2. By Chemical Nature
14.2.3. By Dosage Type
14.2.4. By Functionality
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Chemical Nature
14.3.3. By Dosage Type
14.3.4. By Functionality
14.3.5. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. Turkey
15.2.1.3. South Africa
15.2.1.4. Rest of MEA
15.2.2. By Chemical Nature
15.2.3. By Dosage Type
15.2.4. By Functionality
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Chemical Nature
15.3.3. By Dosage Type
15.3.4. By Functionality
15.3.5. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Chemical Nature
16.1.2.2. By Dosage Type
16.1.2.3. By Functionality
16.1.2.4. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Chemical Nature
16.2.2.2. By Dosage Type
16.2.2.3. By Functionality
16.2.2.4. By End User
16.3. Mexico
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Chemical Nature
16.3.2.2. By Dosage Type
16.3.2.3. By Functionality
16.3.2.4. By End User
16.4. Brazil
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Chemical Nature
16.4.2.2. By Dosage Type
16.4.2.3. By Functionality
16.4.2.4. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Chemical Nature
16.5.2.2. By Dosage Type
16.5.2.3. By Functionality
16.5.2.4. By End User
16.6. Italy
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Chemical Nature
16.6.2.2. By Dosage Type
16.6.2.3. By Functionality
16.6.2.4. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Chemical Nature
16.7.2.2. By Dosage Type
16.7.2.3. By Functionality
16.7.2.4. By End User
16.8. U.K.
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Chemical Nature
16.8.2.2. By Dosage Type
16.8.2.3. By Functionality
16.8.2.4. By End User
16.9. Spain
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Chemical Nature
16.9.2.2. By Dosage Type
16.9.2.3. By Functionality
16.9.2.4. By End User
16.10. BENELUX
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Chemical Nature
16.10.2.2. By Dosage Type
16.10.2.3. By Functionality
16.10.2.4. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Chemical Nature
16.11.2.2. By Dosage Type
16.11.2.3. By Functionality
16.11.2.4. By End User
16.12. China
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Chemical Nature
16.12.2.2. By Dosage Type
16.12.2.3. By Functionality
16.12.2.4. By End User
16.13. Japan
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Chemical Nature
16.13.2.2. By Dosage Type
16.13.2.3. By Functionality
16.13.2.4. By End User
16.14. South Korea
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Chemical Nature
16.14.2.2. By Dosage Type
16.14.2.3. By Functionality
16.14.2.4. By End User
16.15. India
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Chemical Nature
16.15.2.2. By Dosage Type
16.15.2.3. By Functionality
16.15.2.4. By End User
16.16. ASEAN
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Chemical Nature
16.16.2.2. By Dosage Type
16.16.2.3. By Functionality
16.16.2.4. By End User
16.17. Australia and New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Chemical Nature
16.17.2.2. By Dosage Type
16.17.2.3. By Functionality
16.17.2.4. By End User
16.18. GCC Countries
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Chemical Nature
16.18.2.2. By Dosage Type
16.18.2.3. By Functionality
16.18.2.4. By End User
16.19. Turkey
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Chemical Nature
16.19.2.2. By Dosage Type
16.19.2.3. By Functionality
16.19.2.4. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Chemical Nature
16.20.2.2. By Dosage Type
16.20.2.3. By Functionality
16.20.2.4. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Chemical Nature
17.3.3. By Dosage Type
17.3.4. By Functionality
17.3.5. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Croda International
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Evonik Industries AG
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Innophos Holdings Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Roquette Pharma
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. The Dow Chemical Company
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Wacker Chemie AG
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Paulaur Corporation
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Signet Excipients Pvt. Ltd
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Ashland, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. FMC Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Associated British Foods Plc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Archer Daniels Midland Company
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. Lubrizol Corporation
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
18.1.14. Avantor Performance Materials, Inc.
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.14.5.2. Product Strategy
18.1.14.5.3. Channel Strategy
18.1.15. NIPPON SODA CO., LTD.
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.15.5.2. Product Strategy
18.1.15.5.3. Channel Strategy
18.1.16. DFE Pharma
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments
18.1.16.4. Sales Footprint
18.1.16.5. Strategy Overview
18.1.16.5.1. Marketing Strategy
18.1.16.5.2. Product Strategy
18.1.16.5.3. Channel Strategy
18.1.17. Glatt GmbH
18.1.17.1. Overview
18.1.17.2. Product Portfolio
18.1.17.3. Profitability by Market Segments
18.1.17.4. Sales Footprint
18.1.17.5. Strategy Overview
18.1.17.5.1. Marketing Strategy
18.1.17.5.2. Product Strategy
18.1.17.5.3. Channel Strategy
18.1.18. Jost Chemical Co.
18.1.18.1. Overview
18.1.18.2. Product Portfolio
18.1.18.3. Profitability by Market Segments
18.1.18.4. Sales Footprint
18.1.18.5. Strategy Overview
18.1.18.5.1. Marketing Strategy
18.1.18.5.2. Product Strategy
18.1.18.5.3. Channel Strategy
18.1.19. ABITEC Corporation
18.1.19.1. Overview
18.1.19.2. Product Portfolio
18.1.19.3. Profitability by Market Segments
18.1.19.4. Sales Footprint
18.1.19.5. Strategy Overview
18.1.19.5.1. Marketing Strategy
18.1.19.5.2. Product Strategy
18.1.19.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032
Table 3: Global Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032
Table 4: Global Market Value (US$ Mn) Forecast by Functionality, 2017-2032
Table 5: Global Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 6: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 7: North America Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032
Table 8: North America Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032
Table 9: North America Market Value (US$ Mn) Forecast by Functionality, 2017-2032
Table 10: North America Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 12: Latin America Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032
Table 13: Latin America Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032
Table 14: Latin America Market Value (US$ Mn) Forecast by Functionality, 2017-2032
Table 15: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: Europe Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032
Table 18: Europe Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032
Table 19: Europe Market Value (US$ Mn) Forecast by Functionality, 2017-2032
Table 20: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: East Asia Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032
Table 23: East Asia Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032
Table 24: East Asia Market Value (US$ Mn) Forecast by Functionality, 2017-2032
Table 25: East Asia Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 26: South Asia & Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 27: South Asia & Pacific Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032
Table 28: South Asia & Pacific Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032
Table 29: South Asia & Pacific Market Value (US$ Mn) Forecast by Functionality, 2017-2032
Table 30: South Asia & Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 31: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 32: MEA Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032
Table 33: MEA Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032
Table 34: MEA Market Value (US$ Mn) Forecast by Functionality, 2017-2032
Table 35: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Chemical Nature, 2022-2032
Figure 2: Global Market Value (US$ Mn) by Dosage Type, 2022-2032
Figure 3: Global Market Value (US$ Mn) by Functionality, 2022-2032
Figure 4: Global Market Value (US$ Mn) by End User, 2022-2032
Figure 5: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 6: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 9: Global Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032
Figure 12: Global Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032
Figure 15: Global Market Value (US$ Mn) Analysis by Functionality, 2017-2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Functionality, 2022-2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032
Figure 18: Global Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 21: Global Market Attractiveness by Chemical Nature, 2022-2032
Figure 22: Global Market Attractiveness by Dosage Type, 2022-2032
Figure 23: Global Market Attractiveness by Functionality, 2022-2032
Figure 24: Global Market Attractiveness by End User, 2022-2032
Figure 25: Global Market Attractiveness by Region, 2022-2032
Figure 26: North America Market Value (US$ Mn) by Chemical Nature, 2022-2032
Figure 27: North America Market Value (US$ Mn) by Dosage Type, 2022-2032
Figure 28: North America Market Value (US$ Mn) by Functionality, 2022-2032
Figure 29: North America Market Value (US$ Mn) by End User, 2022-2032
Figure 30: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 34: North America Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032
Figure 37: North America Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032
Figure 40: North America Market Value (US$ Mn) Analysis by Functionality, 2017-2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Functionality, 2022-2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032
Figure 43: North America Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 46: North America Market Attractiveness by Chemical Nature, 2022-2032
Figure 47: North America Market Attractiveness by Dosage Type, 2022-2032
Figure 48: North America Market Attractiveness by Functionality, 2022-2032
Figure 49: North America Market Attractiveness by End User, 2022-2032
Figure 50: North America Market Attractiveness by Country, 2022-2032
Figure 51: Latin America Market Value (US$ Mn) by Chemical Nature, 2022-2032
Figure 52: Latin America Market Value (US$ Mn) by Dosage Type, 2022-2032
Figure 53: Latin America Market Value (US$ Mn) by Functionality, 2022-2032
Figure 54: Latin America Market Value (US$ Mn) by End User, 2022-2032
Figure 55: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 59: Latin America Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032
Figure 62: Latin America Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032
Figure 65: Latin America Market Value (US$ Mn) Analysis by Functionality, 2017-2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Functionality, 2022-2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032
Figure 68: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 71: Latin America Market Attractiveness by Chemical Nature, 2022-2032
Figure 72: Latin America Market Attractiveness by Dosage Type, 2022-2032
Figure 73: Latin America Market Attractiveness by Functionality, 2022-2032
Figure 74: Latin America Market Attractiveness by End User, 2022-2032
Figure 75: Latin America Market Attractiveness by Country, 2022-2032
Figure 76: Europe Market Value (US$ Mn) by Chemical Nature, 2022-2032
Figure 77: Europe Market Value (US$ Mn) by Dosage Type, 2022-2032
Figure 78: Europe Market Value (US$ Mn) by Functionality, 2022-2032
Figure 79: Europe Market Value (US$ Mn) by End User, 2022-2032
Figure 80: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 84: Europe Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032
Figure 87: Europe Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032
Figure 90: Europe Market Value (US$ Mn) Analysis by Functionality, 2017-2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by Functionality, 2022-2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032
Figure 93: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 96: Europe Market Attractiveness by Chemical Nature, 2022-2032
Figure 97: Europe Market Attractiveness by Dosage Type, 2022-2032
Figure 98: Europe Market Attractiveness by Functionality, 2022-2032
Figure 99: Europe Market Attractiveness by End User, 2022-2032
Figure 100: Europe Market Attractiveness by Country, 2022-2032
Figure 101: East Asia Market Value (US$ Mn) by Chemical Nature, 2022-2032
Figure 102: East Asia Market Value (US$ Mn) by Dosage Type, 2022-2032
Figure 103: East Asia Market Value (US$ Mn) by Functionality, 2022-2032
Figure 104: East Asia Market Value (US$ Mn) by End User, 2022-2032
Figure 105: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 106: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 107: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 109: East Asia Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032
Figure 110: East Asia Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032
Figure 111: East Asia Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032
Figure 112: East Asia Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032
Figure 113: East Asia Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032
Figure 114: East Asia Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032
Figure 115: East Asia Market Value (US$ Mn) Analysis by Functionality, 2017-2032
Figure 116: East Asia Market Value Share (%) and BPS Analysis by Functionality, 2022-2032
Figure 117: East Asia Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032
Figure 118: East Asia Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 119: East Asia Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 120: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 121: East Asia Market Attractiveness by Chemical Nature, 2022-2032
Figure 122: East Asia Market Attractiveness by Dosage Type, 2022-2032
Figure 123: East Asia Market Attractiveness by Functionality, 2022-2032
Figure 124: East Asia Market Attractiveness by End User, 2022-2032
Figure 125: East Asia Market Attractiveness by Country, 2022-2032
Figure 126: South Asia & Pacific Market Value (US$ Mn) by Chemical Nature, 2022-2032
Figure 127: South Asia & Pacific Market Value (US$ Mn) by Dosage Type, 2022-2032
Figure 128: South Asia & Pacific Market Value (US$ Mn) by Functionality, 2022-2032
Figure 129: South Asia & Pacific Market Value (US$ Mn) by End User, 2022-2032
Figure 130: South Asia & Pacific Market Value (US$ Mn) by Country, 2022-2032
Figure 131: South Asia & Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 132: South Asia & Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 133: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 134: South Asia & Pacific Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032
Figure 135: South Asia & Pacific Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032
Figure 136: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032
Figure 137: South Asia & Pacific Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032
Figure 138: South Asia & Pacific Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032
Figure 139: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032
Figure 140: South Asia & Pacific Market Value (US$ Mn) Analysis by Functionality, 2017-2032
Figure 141: South Asia & Pacific Market Value Share (%) and BPS Analysis by Functionality, 2022-2032
Figure 142: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032
Figure 143: South Asia & Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 144: South Asia & Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 145: South Asia & Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 146: South Asia & Pacific Market Attractiveness by Chemical Nature, 2022-2032
Figure 147: South Asia & Pacific Market Attractiveness by Dosage Type, 2022-2032
Figure 148: South Asia & Pacific Market Attractiveness by Functionality, 2022-2032
Figure 149: South Asia & Pacific Market Attractiveness by End User, 2022-2032
Figure 150: South Asia & Pacific Market Attractiveness by Country, 2022-2032
Figure 151: MEA Market Value (US$ Mn) by Chemical Nature, 2022-2032
Figure 152: MEA Market Value (US$ Mn) by Dosage Type, 2022-2032
Figure 153: MEA Market Value (US$ Mn) by Functionality, 2022-2032
Figure 154: MEA Market Value (US$ Mn) by End User, 2022-2032
Figure 155: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 156: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 157: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 158: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 159: MEA Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032
Figure 160: MEA Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032
Figure 161: MEA Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032
Figure 162: MEA Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032
Figure 163: MEA Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032
Figure 164: MEA Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032
Figure 165: MEA Market Value (US$ Mn) Analysis by Functionality, 2017-2032
Figure 166: MEA Market Value Share (%) and BPS Analysis by Functionality, 2022-2032
Figure 167: MEA Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032
Figure 168: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 169: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 170: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 171: MEA Market Attractiveness by Chemical Nature, 2022-2032
Figure 172: MEA Market Attractiveness by Dosage Type, 2022-2032
Figure 173: MEA Market Attractiveness by Functionality, 2022-2032
Figure 174: MEA Market Attractiveness by End User, 2022-2032
Figure 175: MEA Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
